Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LDL-cholesterol distance to target: A practical tool for guiding lipid-lowering treatment decisions.

Atherosclerosis plus·2026
Same author

Corrigendum to "Heated tobacco product aerosol emission compared to cigarette smoke: A scoping review" [Toxicol. Rep. 16 (2026) 102209].

Toxicology reports·2026
Same author

Under-recognized, under-referred: a multidisciplinary evaluation of fragility fracture management in the emergency setting.

Archives of osteoporosis·2026
Same author

Are we underestimating the benefits of lipid-lowering therapies?

Pharmacological reviews·2026
Same author

Hemostatic Aspects of Interactions Between Anticancer Drugs and Oral Anticoagulants in Patients with Cancer-Associated Venous Thromboembolism.

Seminars in thrombosis and hemostasis·2026
Same author

New frontiers in the treatment of hypercholesterolaemia: oral inhibition of PCSK9.

European heart journal supplements : journal of the European Society of Cardiology·2026

Related Experiment Video

Updated: May 13, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

Gender medicine: a task for the third millennium.

Giovannella Baggio1, Alberto Corsini, Annarosa Floreani

  • 1Internal Medicine Unit, Azienda Ospedaliera di Padova, Via Giustiniani 2, Padua 35125, Italy. giovannella.baggio@sanita.padova.it

Clinical Chemistry and Laboratory Medicine
|March 22, 2013
PubMed
Summary

Gender-specific medicine reveals significant differences in how diseases affect men and women. Understanding these sex-based variations is crucial for improving prevention, diagnosis, and treatment across major medical fields.

More Related Videos

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Human Ovarian Surface Epithelium Organoids as a Platform to Study Tissue Regeneration
07:37

Human Ovarian Surface Epithelium Organoids as a Platform to Study Tissue Regeneration

Published on: August 16, 2024

Related Experiment Videos

Last Updated: May 13, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Human Ovarian Surface Epithelium Organoids as a Platform to Study Tissue Regeneration
07:37

Human Ovarian Surface Epithelium Organoids as a Platform to Study Tissue Regeneration

Published on: August 16, 2024

Area of Science:

  • Medical Science
  • Public Health
  • Clinical Research

Background:

  • Gender-specific medicine, studying disease variations between sexes, remains a neglected area.
  • Significant gender disparities exist in cardiovascular diseases (CVDs), pharmacology, oncology, liver diseases, and osteoporosis.
  • Current medical research and practice often overlook these crucial sex-based differences.

Purpose of the Study:

  • To highlight major issues and gender disparities in five key medical fields: CVDs, pharmacology, oncology, liver diseases, and osteoporosis.
  • To underscore the need for increased awareness and research into sex-based differences in disease.
  • To advocate for the integration of gender as a critical variable in medical research and clinical practice.

Main Methods:

  • Review of existing literature and clinical data on gender differences in disease.
  • Analysis of epidemiological, clinical, and therapeutic aspects of diseases in men and women.
  • Identification of knowledge gaps and areas requiring further investigation.

Main Results:

  • CVDs, the leading cause of mortality in women, show differing risk factors, clinical signs, and drug responses between sexes.
  • Sex-based differences in pharmacokinetics and pharmacodynamics impact drug efficacy and side effects.
  • Gender disparities are observed in cancer incidence, aggressiveness, and prognosis, often underestimated in treatment.
  • Epidemiology and progression of liver diseases vary between men and women, with conflicting evidence on underlying causes.
  • Osteoporosis research and treatment are more established in women, with male osteoporosis being significantly underestimated.

Conclusions:

  • There is an urgent need for basic science and clinical research to better understand and address gender differences in diseases.
  • Integrating gender-specific data is essential for improving disease prevention, diagnosis, and treatment strategies.
  • Systematizing knowledge on gender disparities can optimize patient outcomes and reduce health inequities.